Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Closed
Other
This trial is looking at the combination of ibrutinib with obinutuzumab to treat chronic lymphocytic leukaemia (CLL). The trial is an extension of the IcICLLe trial.
Recruitment start: 4 December 2015
Recruitment end: 31 August 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Hillmen
Bloodwise
NIHR Clinical Research Network: Cancer
Pharmacyclics Inc
Roche
University of Birmingham
Last reviewed: 28 May 2025
CRUK internal database number: 13383
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
